AP NEWS

Investor Expectations to Drive Momentum within ANSYS, Nordic American Tankers, Woodward, GW Pharmaceuticals, CareTrust REIT, and TOCAGEN INC — Discovering Underlying Factors of Influence

November 29, 2018

NEW YORK, Nov. 29, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of ANSYS, Inc. (NASDAQ:ANSS), Nordic American Tankers Limited (NYSE:NAT), Woodward, Inc. (NASDAQ:WWD), GW Pharmaceuticals PLC (NASDAQ:GWPH), CareTrust REIT, Inc. (NASDAQ:CTRE), and TOCAGEN INC (NASDAQ:TOCA), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the links below.

ANSS DOWNLOAD: http://Fundamental-Markets.com/register/?so=ANSS NAT DOWNLOAD: http://Fundamental-Markets.com/register/?so=NAT WWD DOWNLOAD: http://Fundamental-Markets.com/register/?so=WWD GWPH DOWNLOAD: http://Fundamental-Markets.com/register/?so=GWPH CTRE DOWNLOAD: http://Fundamental-Markets.com/register/?so=CTRE TOCA DOWNLOAD: http://Fundamental-Markets.com/register/?so=TOCA

(You may have to copy and paste the link into your browser and hit the [ENTER] key)

The new research reports from Fundamental Markets, available for free download at the links above, examine ANSYS, Inc. (NASDAQ:ANSS), Nordic American Tankers Limited (NYSE:NAT), Woodward, Inc. (NASDAQ:WWD), GW Pharmaceuticals PLC (NASDAQ:GWPH), CareTrust REIT, Inc. (NASDAQ:CTRE), and TOCAGEN INC (NASDAQ:TOCA) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today’s readers below.

-----------------------------------------

Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed November 27th, 2018. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.

-----------------------------------------

ANSYS, INC. (ANSS) REPORT OVERVIEW

ANSYS’s Recent Financial Performance

For the three months ended September 30th, 2018 vs September 30th, 2017, ANSYS reported revenue of $289.42MM vs $275.59MM (up 5.02%) and analysts estimated basic earnings per share $1.06 vs $0.87 (up 21.84%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, ANSYS reported revenue of $1,095.25MM vs $988.47MM (up 10.80%) and analysts estimated basic earnings per share $3.05 vs $3.05 (unchanged). Analysts expect earnings to be released on February 20th, 2019. The report will be for the fiscal period ending December 31st, 2018. The reported EPS for the same quarter last year was $0.97. The estimated EPS forecast for the next fiscal year is $4.67 and is expected to report on February 20th, 2019.

To read the full ANSYS, Inc. (ANSS) report, download it here: http://Fundamental-Markets.com/register/?so=ANSS

-----------------------------------------

NORDIC AMERICAN TANKERS LIMITED (NAT) REPORT OVERVIEW

Nordic American Tankers’ Recent Financial Performance

For the three months ended June 30th, 2018 vs June 30th, 2017, Nordic American Tankers reported revenue of $27.01MM vs $39.10MM (down 30.92%) and analysts estimated basic earnings per share -$0.19 vs -$0.16. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Nordic American Tankers reported revenue of $297.14MM vs $357.45MM (down 16.87%) and analysts estimated basic earnings per share -$1.97 vs -$0.05. Analysts expect earnings to be released on February 11th, 2019. The report will be for the fiscal period ending December 31st, 2018. Reported EPS for the same quarter last year was -$0.20. The estimated EPS forecast for the next fiscal year is $0.02 and is expected to report on February 11th, 2019.

To read the full Nordic American Tankers Limited (NAT) report, download it here: http://Fundamental-Markets.com/register/?so=NAT

-----------------------------------------

WOODWARD, INC. (WWD) REPORT OVERVIEW

Woodward’s Recent Financial Performance

For the three months ended September 30th, 2018 vs September 30th, 2017, Woodward reported revenue of $719.36MM vs $606.79MM (up 18.55%) and analysts estimated basic earnings per share $1.20 vs $1.02 (up 17.65%). For the twelve months ended September 30th, 2018 vs September 30th, 2017, Woodward reported revenue of $2,325.87MM vs $2,098.69MM (up 10.83%) and analysts estimated basic earnings per share $2.93 vs $3.27 (down 10.40%). Analysts expect earnings to be released on January 28th, 2019. The report will be for the fiscal period ending December 31st, 2018. Reported EPS for the same quarter last year was $0.53. The estimated EPS forecast for the next fiscal year is $5.24 and is expected to report on November 6th, 2019.

To read the full Woodward, Inc. (WWD) report, download it here: http://Fundamental-Markets.com/register/?so=WWD

-----------------------------------------

GW PHARMACEUTICALS PLC (GWPH) REPORT OVERVIEW

GW Pharmaceuticals’ Recent Financial Performance

For the three months ended June 30th, 2018 vs June 30th, 2017, GW Pharmaceuticals reported revenue of $3.46MM vs $3.14MM (up 10.17%) and basic earnings per share -$1.26 vs -$2.08. For the twelve months ended September 30th, 2017 vs September 30th, 2016, GW Pharmaceuticals reported revenue of $10.44MM vs $14.69MM (down 28.94%) and analysts estimated basic earnings per share -$6.60 vs -$4.02. Analysts expect earnings to be released on February 4th, 2019. The report will be for the fiscal period ending December 31st, 2018. The reported EPS for the same quarter last year was -$2.43. The estimated EPS forecast for the next fiscal year is $3.42 and is expected to report on November 26th, 2019.

To read the full GW Pharmaceuticals PLC (GWPH) report, download it here: http://Fundamental-Markets.com/register/?so=GWPH

-----------------------------------------

CARETRUST REIT, INC. (CTRE) REPORT OVERVIEW

CareTrust REIT’s Recent Financial Performance

For the three months ended September 30th, 2018 vs September 30th, 2017, CareTrust REIT reported revenue of $39.51MM vs $32.95MM (up 19.92%) and analysts estimated basic earnings per share $0.18 vs $0.15 (up 20.00%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, CareTrust REIT reported revenue of $132.98MM vs $104.68MM (up 27.04%) and analysts estimated basic earnings per share $0.35 vs $0.52 (down 32.69%). Analysts expect earnings to be released on February 26th, 2019. The report will be for the fiscal period ending December 31st, 2018. The reported EPS for the same quarter last year was $0.31. The estimated EPS forecast for the next fiscal year is $1.36 and is expected to report on February 26th, 2019.

To read the full CareTrust REIT, Inc. (CTRE) report, download it here: http://Fundamental-Markets.com/register/?so=CTRE

-----------------------------------------

TOCAGEN INC (TOCA) REPORT OVERVIEW

TOCAGEN INC’s Recent Financial Performance

For the three months ended September 30th, 2018 vs September 30th, 2017, TOCAGEN INC reported revenue of $18.01MM vs $0.01MM (up 179,990.00%) and analysts estimated basic earnings per share -$0.02 vs -$0.50. For the twelve months ended December 31st, 2017 vs December 31st, 2016, TOCAGEN INC reported revenue of $0.04MM vs $0.05MM (down 16.33%) and analysts estimated basic earnings per share -$2.66 vs -$15.22. Analysts expect earnings to be released on March 14th, 2019. The report will be for the fiscal period ending December 31st, 2018. The reported EPS for the same quarter last year was -$0.55. The estimated EPS forecast for the next fiscal year is -$2.70 and is expected to report on March 14th, 2019.

To read the full TOCAGEN INC (TOCA) report, download it here: http://Fundamental-Markets.com/register/?so=TOCA

-----------------------------------------

ABOUT FUNDAMENTAL MARKETS

Fundamental Markets serves thousands of members and have provided research through some of the world’s leading brokerages for over a decade–and continue to be one of the best information sources for investors and investment professionals worldwide. Fundamental Markets’ roster boasts decades of financial experience and includes top financial writers, FINRA® BrokerCheck® certified professionals with current and valid CRD® number designations, as well as Chartered Financial Analyst® (CFA®) designation holders, to ensure up to date factual information for active readers on the topics they care about.

REGISTERED MEMBER STATUS

Fundamental Markets’ oversight and audit staff are registered analysts, brokers, and/or financial advisers (“Registered Members”) working within Equity Research, Media, and Compliance departments. Fundamental Markets’ roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Fundamental Markets have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Fundamental Markets’ Compliance department by Phone, at +1 667-401-0010, or by E-mail at compliance@Fundamental-Markets.com.

LEGAL NOTICES

Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Fundamental Markets, Fundamental Markets members, and/or Fundamental Markets affiliates are not responsible for any gains or losses that result from the opinions expressed. Fundamental Markets makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Fundamental Markets has not been compensated for the publication of this press release by any of the above mentioned companies. Fundamental Markets is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.

Media Contact: Andrew Duffie, Media Department Office: +1 667-401-0010 E-mail: media@Fundamental-Markets.com

© 2018 Fundamental Markets. All Rights Reserved. For republishing permissions, please contact a partner network manager at partnership@Fundamental-Markets.com.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.

AP RADIO
Update hourly